Showing 221 - 240 results of 101,442 for search '(( end point decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 221
  2. 222

    SPL treatment decreases diabetes-induced co-immunoprecipitation (co-IP) of cldn-4 and -8. by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…Also, increased co-IP of cldn-8 with cldn-4 was found under diabetic condition and SPL decreased this interaction (C), densitometric analysis show that these changes were significant (D) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s005" target="_blank">S5 Fig</a>). …”
  3. 223
  4. 224
  5. 225
  6. 226
  7. 227

    Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio by Jani Luukkonen (4339744)

    Published 2017
    “…The TRAcP 5B/5A ratio was decreased in RA and correlated negatively with the amount of phospho-OPN (p<0.05). …”
  8. 228
  9. 229

    At E9.5 Actb<sup>−/−</sup> neural crest cells show a significant decrease of cadherin-11 expression. by Davina Tondeleir (426905)

    Published 2014
    “…We only observed a significant reduction of cadherin-11 intensities in Actb<sup>−/−</sup> neural crest cells at E9.5. …”
  10. 230
  11. 231
  12. 232
  13. 233
  14. 234

    Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

    Published 2024
    “…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). The FMT group also showed a significant reduction in urinary 5-hydroxyindoleacetic acid (5-HIAA) levels from 8.6 to 7.32 mg/L (p = 0.022), while other metabolites showed no significant changes.…”
  15. 235
  16. 236
  17. 237
  18. 238

    Hamster weight as an end-point for leptospiral infection. by Mariana L. Coutinho (337710)

    Published 2013
    “…</b> Control animals sham-immunized with phosphate-buffered saline (PBS) had stable or increasing weights until day 8 or 9 after challenge, after which they lost weight and met the end-point criterion of a 10% weight decrease (lines represent individual animals).…”
  19. 239
  20. 240

    End-point variability and smallest effective ISS. by James P. Herman (304807)

    Published 2013
    “…<p>We define baseline end-point variability (σ<sub>b</sub>) as: the standard deviation of primary saccade gain during the final 50 trials of the baseline phase. …”